leisure time -WSS

leisure time

author：fashion 2025-10-01 15:30:53 - browse：274

A medical device to treat below-the-knee chronic limb-threatening ischemia, Esprit BTK resorbable scaffold, is shown consisted of pieces of geometric shapes that lined up into a pipe on a blue background — health tech coverage from STAT — Cardiovascular doctors are optimistic about Abbott’s new below-knee stent that disappears into the blood vessel’s walls over the course of three years. Courtesy Abbott

An Abbott device that failed in heart disease patients is getting a new life in patients with severe vascular disease.

The device is a below-knee stent that widens clogged blood vessels, and then vanishes into the vessel’s walls over the course of three years. It also delivers a drug that prevents scar tissue from forming — a common risk factor with traditional metal stents that further narrow the vessel.

Abbott’s first dissolvable stent, for coronary artery disease, received Food and Drug Administration approval in 2016. But the company voluntarily pulled the product from the market just over a year later due to “low commercial uptake.” The device also received mixed results in clinical trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： The EPA's new lead rule: How one expert crunched the numbers

WSS

After John Oliver segment, STAT readers share their opioid

Some of the ways extreme heat will change life as we know it

Pediatric cancer treatments threatened by a new FDA policy

As biotech industry slumps, bioscience job market is upside down

With clinical trial data readouts, here's how to spot spin

Flagship Pioneering launches a new biotech in two countries

knowledge

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Some of the ways extreme heat will change life as we know it

After affirmative action ruling, medical educators look to 'holistic review'

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Affirmative action in medical school literally saved lives

With clinical trial data readouts, here's how to spot spin

How one medical school became remarkably diverse

Faced with fears of OxyContin misuse, sales reps touted its safety

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

An innovative path out of biotech’s “valley of death”

focus

Flagship Pioneering launches a new biotech in two countries

What don’t we know about an Alzheimer’s drug side effect?

Mayo Clinic plans $5B tech

Some of the ways extreme heat will change life as we know it

What to do when lifesaving products contribute to climate change

Diagnostic tests are hitting their mathematical limits

focus

Wikipedia

hotspot

leisure time